2015: "To examine the emergence potential (the potential to infect humans) of circulating bat CoVs, we built a chimeric virus encoding a novel, zoonotic CoV spike protein -from the RsSHC014-CoV sequence that was isolated from Chinese horseshoe bats" https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4797993/#__ffn_sectitle




"Using the SARS-CoV reverse genetics system2, we generated and characterized a chimeric virus expressing the spike of bat coronavirus SHC014 in a mouse-adapted SARS-CoV backbone."
"The results indicate that group 2b viruses encoding the SHC014 spike..replicate efficiently in primary human airway cells and achieve in vitro titers equivalent to epidemic strains of SARS-CoV."
THEY DID NOT CONSIDER T-CELLS!
"Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein."
"Evaluation of available SARS-based immune-therapeutic and prophylactic modalities revealed poor efficacy; both monoclonal antibody and vaccine approaches failed to neutralize and protect from infection with CoVs using the novel spike protein."
"Wild-type SARS-CoV (Urbani), mouse-adapted SARS-CoV (MA15) and chimeric SARS-like CoVs were cultured on Vero E6 cells (
obtained from United States Army Medical Research Institute of Infectious Diseases
)"


"experiments were similar to those using an HIV-based pseudovirus, prepared as previously described10, and examined on HeLa cells (
Wuhan Institute of Virology
)


"
Human lungs for HAE cultures were procured under University of North Carolina at Chapel Hill Institutional Review Board–approved protocols.
"


These studies were initiated before the US Government Deliberative Process Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS and SARS Viruses ( http://www.phe.gov/s3/dualuse/Documents/gain-of-function.pdf)
"
This paper has been reviewed by the funding agency, the NIH. Continuation of these studies was requested, and this has been approved by the NIH
.
SARS-CoV is a select agent."


SARS-CoV is a select agent."
These are the authors of the research, should we not have heard a lot more from them since the SARSCov2 outbreak?

National Center for Toxicological Research, Food and Drug Administration, Jefferson, Arkansas USA

Wuhan Lab was well on this path in 2010. Thread: https://twitter.com/robinmonotti/status/1306440729552711681?s=19
Will we get an answer? https://twitter.com/robinmonotti/status/1309379114458021889?s=19
Ralph Baric: "We can engineer a virus without leaving any trace. We engineered it so antibodies would not work": THEY DID NOT CONSIDER T-CELLS https://twitter.com/Carlo_bis/status/1308607670920843265/video/1